SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation.
View / Open Files
Authors
Jolin, Helen E
Dugourd, Aurélien
Guénantin, Anne-Claire
Mahler-Araujo, Betania
Lam, Brian YH
Dale, Martin
Carobbio, Stefania
Kaser, Arthur
Fallon, Padraic G
Publication Date
2021-09Journal Title
Nat Metab
ISSN
2522-5812
Publisher
Springer Science and Business Media LLC
Volume
3
Issue
9
Pages
1150-1162
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Bidault, G., Virtue, S., Petkevicius, K., Jolin, H. E., Dugourd, A., Guénantin, A., Leggat, J., et al. (2021). SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation.. Nat Metab, 3 (9), 1150-1162. https://doi.org/10.1038/s42255-021-00440-5
Abstract
Macrophages exhibit a spectrum of activation states ranging from classical to alternative activation1. Alternatively, activated macrophages are involved in diverse pathophysiological processes such as confining tissue parasites2, improving insulin sensitivity3 or promoting an immune-tolerant microenvironment that facilitates tumour growth and metastasis4. Recently, the metabolic regulation of macrophage function has come into focus as both the classical and alternative activation programmes require specific regulated metabolic reprogramming5. While most of the studies regarding immunometabolism have focussed on the catabolic pathways activated to provide energy, little is known about the anabolic pathways mediating macrophage alternative activation. In this study, we show that the anabolic transcription factor sterol regulatory element binding protein 1 (SREBP1) is activated in response to the canonical T helper 2 cell cytokine interleukin-4 to trigger the de novo lipogenesis (DNL) programme, as a necessary step for macrophage alternative activation. Mechanistically, DNL consumes NADPH, partitioning it away from cellular antioxidant defences and raising reactive oxygen species levels. Reactive oxygen species serves as a second messenger, signalling sufficient DNL, and promoting macrophage alternative activation. The pathophysiological relevance of this mechanism is validated by showing that SREBP1/DNL is essential for macrophage alternative activation in vivo in a helminth infection model.
Sponsorship
British Heart Foundation (None)
Wellcome Trust (100574/Z/12/Z)
Medical Research Council (MC_UU_12012/5)
Wellcome Trust (106260/Z/14/Z)
European Commission (223450)
European Research Council (648889)
European Research Council (669879)
British Heart Foundation (RG/18/7/33636)
MRC (MC_UU_00014/2)
Medical Research Council (G0802051)
Medical Research Council (MC_G0802535)
Medical Research Council (G0400192)
Medical Research Council (MC_UU_12012/2)
Identifiers
PMC7611716, 34531575
External DOI: https://doi.org/10.1038/s42255-021-00440-5
This record's URL: https://www.repository.cam.ac.uk/handle/1810/329602
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.